- Conditions
- Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +25 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- University of California San Francisco San Francisco, California, United States
- Hartford Healthcare Hartford, Connecticut, United States
- Yale University New Haven, Connecticut, United States
Clinical trial condition
Lethal Congenital Contracture Syndrome 2
Explore clinical trials studying Lethal Congenital Contracture Syndrome 2. Study availability and eligibility vary by location and protocol.
10 public trials
3 recruiting studies
Lethal Congenital Contracture Syndrome 2 trial results
NCT07111520
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Stanford Cancer Institute Stanford, California, United States
- Yale University New Haven, Connecticut, United States
- Moffit Cancer Center Tampa, Florida, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT05142189
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +19 more
- Locations
-
- University of Kentucky Chandler Medical Center Lexington, Kentucky, United States
- Norton Cancer Institute Louisville, Kentucky, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Ohio State University Columbus, Ohio, United States
Active, not recruiting
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
NCT05057013
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +80 more
- Locations
-
- Royal Marsden NHS Foundation Trust London, United Kingdom
- The Christie Hospital Manchester, United Kingdom
- Freeman Hospital, Newcastle Newcastle, United Kingdom
- Churchill Hospital Oxford, United Kingdom
Active, not recruiting
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
NCT02912949
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- The Oncology Institute of Hope and Innovation Cerritos, California, United States
- University of California Irvine Irvine, California, United States
- Stanford University Palo Alto, California, United States
NCT03321981
- Conditions
- Breast Cancer Metastatic, Lethal Congenital Contracture Syndrome 2
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- HCA Midwest Health Kansas City, Kansas, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
- Institut Jules Bordet Brussels, Belgium
NCT00734305
- Conditions
- Advanced Solid Tumors, Lethal Congenital Contracture Syndrome 2, Neoplasms
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- The Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
Completed
A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer
NCT00994123
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Birmingham, Alabama, United States
- Tucson, Arizona, United States
- Loma Linda, California, United States
- Sacramento, California, United States
NCT00740532
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- Istituto Clinico Humanitas Rozzano, Milan, Italy
NCT00730470
- Conditions
- Advanced Solid Tumors, Fibromatosis, Gingival, 2, Lethal Congenital Contracture Syndrome 2
- Locations
-
- Dana Faber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Memorial Sloan-Kettering Cancer Centre New York, United States